Published on in Vol 15 (2026)

This is a member publication of JISC

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68785, first published .
Differentiating the COVID-19 Infection and Vaccine Experiences of Patients With Systemic, Single Organ, and Overlap Immune-Mediated Inflammatory Disease: Protocol for a Secondary Analysis for Enhancing COVID-19 Vaccine Pharmacovigilance

Differentiating the COVID-19 Infection and Vaccine Experiences of Patients With Systemic, Single Organ, and Overlap Immune-Mediated Inflammatory Disease: Protocol for a Secondary Analysis for Enhancing COVID-19 Vaccine Pharmacovigilance

Differentiating the COVID-19 Infection and Vaccine Experiences of Patients With Systemic, Single Organ, and Overlap Immune-Mediated Inflammatory Disease: Protocol for a Secondary Analysis for Enhancing COVID-19 Vaccine Pharmacovigilance

Meredith Leston   1 , BA, MPH ;   José M Ordóñez-Mena   1 , PhD ;   Xinchun Gu   1 , PhD ;   Mark Joy   1 , PhD ;   F D Richard Hobbs   1, 2 , Prof Dr Med ;   Lennard Y W Lee   1 , PhD ;   Ioannis Parodis   3 , PhD ;   Laura Andreoli   4 , PhD ;   Nelly Ziade   5 , PhD ;   Latika Gupta   6 , PhD ;   Vikas Agarwal   7 , PhD ;   Richard Conway   8 , Prof Dr Med ;   John Isaacs   9, 10 , MB, BS, PhD ;   Jeffrey Curtis   11 , Prof Dr Med ;   Alessia Alunno   12 , PhD ;   Stefan Siebert   13 , Prof Dr Med ;   Ori Elkayam   14 , MD ;   Karen Schreiber   15, 16, 17 , PhD ;   Simon de Lusignan   18 , Prof Dr Med

1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

2 Oxford Institute of Digital Health, University of Oxford, Oxford, United Kingdom

3 Karolinska University Hospital, Stockholm, Sweden

4 University of Brescia, Brescia, Italy

5 St Joseph University, Beirut, Lebanon

6 The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom

7 Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

8 St James' Hospital, Dublin, Ireland

9 Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom

10 Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

11 University of Alabama at Birmingham, Birmingham, AL, United States

12 Internal Medicine and Nephrology Division, MeSVA Department, University of L'Aquila, L'Aquila, Italy

13 University of Glasgow, Glasgow, United Kingdom

14 Department of Rheumatology, Tel Aviv Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel

15 Danish Center for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark

16 Institute for Regional Health, Southern Danish University, Odense, Denmark

17 Thrombosis and Haemostasis, Guy’s and St Thomas NHS Foundation Trust, London, United Kingdom

18 University of Oxford, Oxford, United Kingdom

Corresponding Author:

  • Meredith Leston, BA, MPH
  • Nuffield Department of Primary Care Health Sciences
  • University of Oxford
  • Radcliffe Primary Care Building, Radcliffe Observatory Quarter
  • Woodstock Rd
  • Oxford OX2 6GG
  • United Kingdom
  • Phone: 44 01865 617855
  • Email: meredith.leston@phc.ox.ac.uk